Follow
Mahitosh Mandal
Mahitosh Mandal
Professor, School of Medical Science and Technology,Indian Institute of Technology, Kharagpur, India
Verified email at smst.iitkgp.ac.in
Title
Cited by
Cited by
Year
Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor
A Mazumdar, RA Wang, SK Mishra, L Adam, R Bagheri-Yarmand, ...
Nature cell biology 3 (1), 30-37, 2001
4562001
Cell cycle-dependent modulation of telomerase activity in tumor cells
X Zhu, R Kumar, M Mandal, N Sharma, HW Sharma, U Dhingra, ...
Proceedings of the National Academy of Sciences 93 (12), 6091-6095, 1996
4051996
Antiproliferative effects of honey and of its polyphenols: a review
SK Jaganathan, M Mandal
Journal of Biomedicine and Biotechnology 2009, 2009
3842009
Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells
RK Vadlamudi, L Adam, RA Wang, M Mandal, D Nguyen, A Sahin, ...
Journal of Biological Chemistry 275 (46), 36238-36244, 2000
3032000
Regulation of cyclooxygenase-2 pathway by HER2 receptor
R Vadlamudi, M Mandal, L Adam, G Steinbach, J Mendelsohn, R Kumar
Oncogene 18 (2), 305-314, 1999
3031999
A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm
R Kumar, RA Wang, A Mazumdar, AH Talukder, M Mandal, Z Yang, ...
Nature 418 (6898), 654-657, 2002
2772002
Bcl-2 modulates telomerase activity
M Mandal, R Kumar
Journal of Biological Chemistry 272 (22), 14183-14187, 1997
2751997
Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells
D Bandyopadhyay, M Mandal, L Adam, J Mendelsohn, R Kumar
Journal of Biological Chemistry 273 (3), 1568-1573, 1998
2701998
The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer
P Venkatesan, N Puvvada, R Dash, BNP Kumar, D Sarkar, B Azab, ...
Biomaterials 32 (15), 3794-3806, 2011
2412011
Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E‐cadherin down‐regulation, vimentin expression, and aggressive …
M Mandal, JN Myers, SM Lippman, FM Johnson, MD Williams, S Rayala, ...
Cancer 112 (9), 2088-2100, 2008
2362008
Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1
L Adam, R Vadlamudi, M Mandal, J Chernoff, R Kumar
Journal of Biological Chemistry 275 (16), 12041-12050, 2000
2122000
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer
BA Schiff, AB McMurphy, SA Jasser, MN Younes, D Doan, OG Yigitbasi, ...
Clinical cancer research 10 (24), 8594-8602, 2004
1942004
Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
R Bharti, G Dey, M Mandal
Cancer letters 375 (1), 51-61, 2016
1882016
Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
R Kumar, M Mandal, A Lipton, H Harvey, CB Thompson
Clinical Cancer Research 2 (7), 1215-1219, 1996
1871996
Apoptotic effect of eugenol in human colon cancer cell lines
SK Jaganathan, A Mazumdar, D Mondhe, M Mandal
Cell biology international 35 (6), 607-615, 2011
1832011
Autophagy: cancer’s friend or foe?
SK Bhutia, S Mukhopadhyay, N Sinha, DN Das, PK Panda, SK Patra, ...
Advances in cancer research 118, 61-95, 2013
1822013
Nuclear targeting of Bax during apoptosis in human colorectal cancer cells
M Mandal, L Adam, J Mendelsohn, R Kumar
Oncogene 17 (8), 999-1007, 1998
1771998
An ethnobotanical study of traditional anti-inflammatory plants used by the Lohit community of Arunachal Pradesh, India
ND Namsa, H Tag, M Mandal, P Kalita, AK Das
Journal of ethnopharmacology 125 (2), 234-245, 2009
1682009
Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells
R Bagheri-Yarmand, M Mandal, AH Taludker, RA Wang, RK Vadlamudi, ...
Journal of Biological Chemistry 276 (31), 29403-29409, 2001
1672001
PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes
I Pal, M Mandal
Acta Pharmacologica Sinica 33 (12), 1441-1458, 2012
1662012
The system can't perform the operation now. Try again later.
Articles 1–20